STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] TPG RE Finance Trust, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

TPG RE Finance Trust (TRTX): Schedule 13G/A Amendment No. 5 reports updated beneficial ownership by TPG GP A, LLC, James G. Coulter, and Jon Winkelried. TPG GP A is shown with 2,392,863 shares (3.1%), Mr. Coulter with 2,492,170 shares (3.2%), and Mr. Winkelried with 2,392,863 shares (3.1%). The filing indicates ownership of 5 percent or less of the class.

All reported voting and dispositive powers are shared, with no sole voting or dispositive power listed for any reporting person. Shares outstanding were 78,261,346 as of October 24, 2025. The amendment is filed jointly, reflecting TPG’s organizational control relationships over entities that directly hold TRTX common stock, and includes a disclaimer by Messrs. Coulter and Winkelried regarding beneficial ownership beyond their pecuniary interests.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership in Row 11 above is based on a total of 78,261,346 shares of Common Stock (as defined below) outstanding as of October 24, 2025 as reported on the Issuer's (as defined below) Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "Commission") on October 28, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership in Row 11 above is based on a total of 78,261,346 shares of Common Stock outstanding as of October 24, 2025 as reported on the Issuer's Quarterly Report on Form 10-Q filed with the Commission on October 28, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership in Row 11 above is based on a total of 78,261,346 shares of Common Stock outstanding as of October 24, 2025 as reported on the Issuer's Quarterly Report on Form 10-Q filed with the Commission on October 28, 2025.


SCHEDULE 13G



TPG GP A, LLC
Signature:/s/ Martin Davidson
Name/Title:Martin Davidson / Chief Accounting Officer
Date:11/14/2025
James G. Coulter
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer on behalf of James G. Coulter (1)
Date:11/14/2025
Jon Winkelried
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer on behalf of Jon Winkelried (2)
Date:11/14/2025

Comments accompanying signature: (1) Gerald Neugebauer is signing on behalf of Mr. Coulter pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Coulter on February 7, 2024 (SEC File No. 001-41617). (2) Gerald Neugebauer is signing on behalf of Mr. Winkelried pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Winkelried on February 7, 2024 (SEC File No. 001-41617).
Exhibit Information

Exhibit 1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* ________________________ * Incorporated herein by reference to the Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG GP A, LLC, TPG Advisors VII, Inc., TPG Advisors VI, Inc., TPG Advisors VI-AIV, Inc., TPG Asia Advisors VI, Inc., David Bonderman, James G. Coulter, Jon Winkelried and Karl Peterson dated as of January 18, 2022, which was previously filed with the Commission as Exhibit 1 to Amendment No. 4 to Schedule 13D filed by TPG GP A, LLC, David Bonderman, James G. Coulter and Jon Winkelried on January 18, 2022 with respect to the shares of common stock of Allogene Therapeutics, Inc.

FAQ

What did TRTX disclose in this Schedule 13G/A Amendment No. 5?

It reports beneficial ownership by TPG GP A, LLC (3.1%), James G. Coulter (3.2%), and Jon Winkelried (3.1%), all with shared voting and dispositive power.

How many TRTX shares are beneficially owned by each reporting person?

TPG GP A: 2,392,863; James G. Coulter: 2,492,170; Jon Winkelried: 2,392,863.

What percentage of TRTX does each reporting person represent?

TPG GP A: 3.1%; James G. Coulter: 3.2%; Jon Winkelried: 3.1%.

What was the total TRTX shares outstanding used for these calculations?

The percentages are based on 78,261,346 shares outstanding as of October 24, 2025.

Do the reporting persons have sole or shared voting/dispositive power?

Each reports 0 sole voting and dispositive power and shared power over the disclosed shares.

Does the filing indicate the holders own less than 5% of TRTX?

Yes. Item 5 notes ownership of 5 percent or less of the class for the reporting persons.

Who are the filers on this 13G/A for TRTX?

The filing is made jointly by TPG GP A, LLC, James G. Coulter, and Jon Winkelried.
Tpg Re Finance T

NYSE:TRTX

TRTX Rankings

TRTX Latest News

TRTX Latest SEC Filings

TRTX Stock Data

705.13M
71.04M
6.14%
84.66%
5.77%
REIT - Mortgage
Real Estate Investment Trusts
Link
United States
SAN FRANCISCO